BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24954546)

  • 21. WT1 expression at diagnosis does not predict survival in pediatric AML: a report from the Children's Oncology Group.
    Noronha SA; Farrar JE; Alonzo TA; Gerbing RB; Lacayo NJ; Dahl GV; Ravindranath Y; Arceci RJ; Loeb DM
    Pediatr Blood Cancer; 2009 Dec; 53(6):1136-9. PubMed ID: 19618455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of Wilms' tumor 1 helper peptide OCV-501 in elderly patients with acute myeloid leukemia: a multicenter, randomized, double-blind, placebo-controlled phase 2 trial.
    Kiguchi T; Yamaguchi M; Takezako N; Miyawaki S; Masui K; Ihara Y; Hirota M; Shimofurutani N; Naoe T
    Cancer Immunol Immunother; 2022 Jun; 71(6):1419-1430. PubMed ID: 34677647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multigene array for measurable residual disease detection in AML patients undergoing SCT.
    Goswami M; McGowan KS; Lu K; Jain N; Candia J; Hensel NF; Tang J; Calvo KR; Battiwalla M; Barrett AJ; Hourigan CS
    Bone Marrow Transplant; 2015 May; 50(5):642-51. PubMed ID: 25665046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of the Wilms' tumor gene WT1 in head and neck squamous cell carcinoma.
    Oji Y; Inohara H; Nakazawa M; Nakano Y; Akahani S; Nakatsuka S; Koga S; Ikeba A; Abeno S; Honjo Y; Yamamoto Y; Iwai S; Yoshida K; Oka Y; Ogawa H; Yoshida J; Aozasa K; Kubo T; Sugiyama H
    Cancer Sci; 2003 Jun; 94(6):523-9. PubMed ID: 12824878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma.
    Oji Y; Yamamoto H; Nomura M; Nakano Y; Ikeba A; Nakatsuka S; Abeno S; Kiyotoh E; Jomgeow T; Sekimoto M; Nezu R; Yoshikawa Y; Inoue Y; Hosen N; Kawakami M; Tsuboi A; Oka Y; Ogawa H; Souda S; Aozasa K; Monden M; Sugiyama H
    Cancer Sci; 2003 Aug; 94(8):712-7. PubMed ID: 12901797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peri-transplant flow-MRD assessment of cells with leukemic stem cells (LSC) associated phenotype in AML patients undergoing allogeneic stem cell transplantation in CR.
    Klyuchnikov E; Badbaran A; Massoud R; Freiberger P; Wolschke C; Ayuk F; Fehse B; Bacher U; Kröger N
    Leukemia; 2024 Feb; 38(2):386-388. PubMed ID: 38263432
    [No Abstract]   [Full Text] [Related]  

  • 27. Testicular myeloid sarcoma: a relapse of acute myeloid leukaemia after allogeneic peripheral blood stem cell transplantation- a rare presentation.
    Alam S; Palaniyandy V; Thirunavukkarasu C; Kumaresan N
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35304354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [An interlaboratory comparison study on the detection of RUNX1-RUNX1T1 fusion transcript levels and WT1 transcript levels].
    Qin YZ; Zhu LW; Lin S; Geng SX; Liu SW; Cheng H; Wu CY; Xiao M; Li XQ; Hu RP; Wang LL; Liu HY; Ma DX; Guan T; Ye YX; Niu T; Cen JN; Lu LS; Sun L; Yang TH; Wang YG; Li T; Wang Y; Li QH; Zhao XS; Li LD; Chen WM; Long LY; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):889-894. PubMed ID: 31856435
    [No Abstract]   [Full Text] [Related]  

  • 29. Features of the TCR repertoire associate with patients' clinical and molecular characteristics in acute myeloid leukemia.
    Pospiech M; Tamizharasan M; Wei YC; Kumar AMS; Lou M; Milstein J; Alachkar H
    Front Immunol; 2023; 14():1236514. PubMed ID: 37928542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute myeloid leukemia with paraneoplastic pemphigus successfully treated with a personalized antileukemic and immunosuppressive strategy.
    Iovene FR; Santinelli E; Armiento D; Sarlo C; Bancone C; Silvestri L; Erculei S; Sanhust MG; Cristiano A; Fabiani E; Divona M; Page C; Di Zenzo G; Cantonetti M; Rigacci L
    Ann Hematol; 2024 May; ():. PubMed ID: 38780802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel postremission strategies in adults with acute myeloid leukemia.
    Lancet JE; Karp JE
    Curr Opin Hematol; 2009 Mar; 16(2):105-11. PubMed ID: 19468272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide.
    Ichinohasama R; Oji Y; Yokoyama H; Takeuchi K; Fujiwara T; Ishizawa K; Taniguchi O; Tsuboi A; Oka Y; Sugiyama H
    Cancer Sci; 2010 May; 101(5):1089-92. PubMed ID: 20180815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic features and outcomes of allogeneic transplantation in patients with WT1-mutated myeloid neoplasms.
    Baranwal A; Basmaci R; He R; Viswanatha D; Greipp P; Murthy HS; Foran J; Palmer J; Hogan WJ; Litzow MR; Hefazi M; Mangaonkar A; Shah MV; Al-Kali A; Alkhateeb HB
    Blood Adv; 2024 Feb; 8(3):562-570. PubMed ID: 38011614
    [No Abstract]   [Full Text] [Related]  

  • 34. Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study.
    Bhatnagar B; Kohlschmidt J; Orwick SJ; Buelow DR; Fobare S; Oakes CC; Kolitz JE; Uy G; Stock W; Powell BL; Nicolet D; Hertlein EK; Mrózek K; Blachly JS; Eisfeld AK; Baker SD; Byrd JC
    Blood Adv; 2023 Aug; 7(16):4671-4675. PubMed ID: 37603350
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential Expression of LMNA/C and Insulin Receptor Transcript Variants in Peripheral Blood Mononuclear Cells of Leukemia Patients.
    Alshaalan KS; Albawardi TK; Zhra M; Bin Sulaiman N; Jnied OY; Saleem RA; Aljada A
    J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731097
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute myeloid leukemia stem cell signature gene EMP1 is not an eligible therapeutic target.
    Van Camp L; Depreter B; De Wilde J; Hofmans M; Van der Linden M; Terras E; Chantrain C; Dedeken L; Van Damme A; Uyttebroeck A; Lammens T; De Moerloose B
    Pediatr Res; 2024 Jun; ():. PubMed ID: 38879624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyarthritis due to metastatic calcinosis in a patient with new
    Rajão Martins F; Gonçalves F; Guedes A; Sequeira G; Ribeiro C
    Scand J Rheumatol; 2024 May; 53(3):220-222. PubMed ID: 38224230
    [No Abstract]   [Full Text] [Related]  

  • 38. [Advances in autologous stem cell transplantation for acute myeloid leukemia].
    Zhao YQ; Feng SZ
    Zhonghua Xue Ye Xue Za Zhi; 2019 Mar; 40(3):247-251. PubMed ID: 30929397
    [No Abstract]   [Full Text] [Related]  

  • 39. ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia.
    Lipreri da Silva JC; Coelho-Silva JL; Vicari HP; Lima K; Rego EM; Traina F; Machado-Neto JA
    Hematol Transfus Cell Ther; 2024; 46(1):101-105. PubMed ID: 37541806
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.